Click here to narrow your options by answering a few questions.

Prostate Cancer
Treatment Guide™

Experts in Treating Prostate Cancer
Treatment
Description
Prostate Cancer
Patient Profile
Prostate Cancer
Treatments
Prostate Cancer
Survival Rates
Prostate Cancer
Side Effects
Therapy News View Procedures Share Your Experience

Radiation
Therapy

Prostate Radiation Therapy

EBRT or electron beam radiation therapy aims external radiation at prostate cancer cells. Prostate Radiation
Therapy

EBRT or electron beam radiation therapy aims external radiation at prostate cancer cells.

click to learn more

Learn More

Using Radiation Therapy

IMRT and 3D-CRT are newer versions of EBRT and are non-invasive. Using Radiation Therapy

IMRT and 3D-CRT are newer versions of EBRT and are non-invasive.

click to learn more

Learn More

Radiation Treatment

Radiation therapy generally requires 5 treatments per week over 6-8 weeks. Radiation Treatment

Radiation therapy generally requires 5 treatments per week over 6-8 weeks.

click to learn more

Learn More

External Radiation Outcomes

Multiple long- and short-term studies indicate success rates over 85% especially when used with other therapies. External Radiation
Outcomes

Multiple long- and short-term studies indicate success rates over 85% especially when used with other therapies.

click to learn more

Learn More

Radiation
Side Effects

May include tiredness, diarrhea, skin irritation, upset stomach, frequent or burning urination, and proctitis. Radiation
Side Effects

May include tiredness, diarrhea, skin irritation, upset stomach, frequent or burning urination, and proctitis.

click to learn more

Learn More

Prostate News

Click here for the latest news on Radiation Therapy.Prostate News

Click here for the latest news on Radiation Therapy.

click to learn more

Learn More

Radiation Therapy
Videos

Click here to view Radiation Therapy procedures. Radiation Therapy
Videos

Click here to view Radiation Therapy procedures.

click to learn more

Learn More

Radiation Therapy
Experiences


Click here to share your Radiation Therapy experiences.Radiation Therapy
Experiencse

Click here to share your Radiation Therapy experiences.

click to learn more


Learn More

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Prostatectomy

Robotic Prostatectomy

Watchful
Waiting

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Results of Treating Prostate Cancer with Radiation Therapy and Brachytherapy

“12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer”
Louis Potters, Carol Morgenstern, Emil Calugaru, Paul Fearn, Anup Jassal, Joseph Presser and Edward Mullen The Journal of Urology 173 (2005) 1562-1566

Physicians reviewed the postoperative outcomes of 1,449 consecutive prostate cancer patients treated with permanent brachytherapy between 1992 and 2000. These patients were generally around 68 years old with a prostate specific antigen level of 10.1, 55 percent had a Gleason score of 6 and 28 percent had a Gleason score of 7. For many, brachytherapy was not their initial or only treatment. There were 400 patients (27%) who received neoadjuvant hormone therapy and 301 (20%) received a combination of external radiation and brachytherapy. After 82 months, 39 patients were at risk for 144 months. The overall survival rate 12 years following was 81 percent and the disease specific survival rate was 93 percent. After 12 years the American Society for Therapeutic Radiology and Oncology (ASTRO) defined the biochemical-free recurrence at 81 percent, ASTRO-Kattan at 78 percent, ASTRO-Last Call at 74 percent, and Houston at 77 percent. Using the ASTRO-Kattan definition, patients at low risk could achieve 89 percent biochemical-free recurrence, those at intermediate risk 78 percent, and those at high risk 63 percent.


“European Collaborative Group on Prostate Brachytherapy: Preliminary Report in 1175 Patients.”
S. Langleya, R. Laingb, A. Hendersona, S. Aaltomaac, V. Katajad, J.-E. Palmgrend, F. Bladoue, N. Salemf, G. Sermente, L. Navag, A. Losah, G. Guazzonih, F. Guedeai, F. Aguiloj, J.F. Suarezj
European Urology 46 (2004) 565­570

The goal of this study was to create a multi-center database of a large span of prostate cancer patients treated with brachytherapy across Europe. To reach this goal 1,175 patients files were included, all of which were registered due to the comprehensive data presented. A patient follow-up was given at five years. Prior hormone therapy treatments were reported in 492 of 1,175 patients (41.9%). France, UK, and Finland reported administering 270 of 860 (31.4%) patients with an antiandrogen and 206 of 860 (24.0%) with a luteinising hormone-releasing hormone (LHRH). Also, 118 patients from France and Italy received electron beam radiation therapy. After a thorough analysis of the database, the study revealed that patient selection has been made optimal both in terms of brachytherapy outcomes and side effects. These results prove that physicians are able to refine treatment choice and administration for their patients. Furthermore, the database indicates that brachytherapy is a well-established treatment option for prostate cancer.

 
 
 
 

 
Prostate Cancer Patient Discussion Group

 

 
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Resources     Add URL      Site Map